Articles From: Incyte Announces Top-Line Results from RELIEF Trial of Ruxolitinib in Patients with Polycythemia Vera to Independent Bank Group Reports Second Quarter Financial Results


Incyte Corporation (Nasdaq: INCY) today announced top-line results from RELIEF, a randomized, double-blind clinical trial designed to compare symptom improvement in 110 patients with polycythemia vera (PV) treated with ruxolitinib versus patients treated with hydroxyurea (HU). While positive trends were observed in favor of ruxolitinib, the trial did not achieve statistical significance for the primary endpoint as measured by the proportion of patients with ≥ 50% reduction in a defined cluster of symptoms that included tiredness, itching, muscle aches, night sweats and sweats while awake at week 16 compared to baseline.
Sign-up for Incyte Announces Top-Line Results from RELIEF Trial of Ruxolitinib in Patients with Polycythemia Vera investment picks
Incyte Corporation (Nasdaq: INCY) today reported 2014 second-quarter financial results, including revenue from Jakafi ® (ruxolitinib), which is approved by the U.S. Food & Drug Administration (FDA) for the treatment of patients with intermediate or high-risk myelofibrosis (MF). The Company highlighted its strong financial position, driven by growing Jakafi sales in the U.S. and Jakavi ® (ruxolitinib) royalties outside the U.S., as well as the submission of the ruxolitinib supplemental New Drug Application (sNDA) in the U.S. for patients with uncontrolled polycythemia vera (PV). The Company also discussed its expanding clinical pipeline, which includes pivotal as well as proof of concept studies, and the multiple data presentations for the Company’s product candidates that were made at the recent American Society of Clinical Oncology (ASCO) meeting.
Sign-up for Incyte Reports 2014 Second-Quarter Financial Results and Updates Shareholders on Key Clinical Programs investment picks
Incyte Corporation (Nasdaq:INCY) announced today it will present at the 21 st Annual BioCentury NewsMakers Conference on Friday, September 26, 2014 at 2:00 p.m. (EDT) in New York.
Sign-up for Incyte to Present at the 21st Annual BioCentury NewsMakers Conference investment picks
Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its second quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, July 31, 2014.
Sign-up for Incyte to Report Second Quarter 2014 Financial Results on July 31 investment picks
Independence Bancshares, Inc. (OTC: IEBS) announced that Gordon A.
Sign-up for Independence Bancshares CEO, Gordon Baird, Elected to ABA Solutions, Inc. Board of Directors investment picks
Independence Bank (OTCBB: IDPK) announced today unaudited net income of $982,000 or $0.20 per basic share for the three months ended June 30, 2014, an increase of 204% as compared to $322,000 or $0.07 per basic share for the same period a year ago.
Sign-up for Independence Bank Announces Second Quarter 2014 Financial Results investment picks
STAMFORD, Conn., Aug.
Sign-up for Independence Holding Company Announces 2014 Second-Quarter and Six-Month Results investment picks
STAMFORD, Conn., June 26, 2014 (GLOBE NEWSWIRE) -- Independence Holding Company (NYSE:IHC) today reported declaration of its semi-annual cash dividend of $0.035 per share of common stock, payable to stockholders of record on July 7, 2014, with a payment date of July 21, 2014.
Sign-up for Independence Holding Company Announces Semi-Annual Cash Dividend investment picks
2014/8/1
Independence Realty Trust, Inc. (“IRT”) (NYSE MKT: IRT) today announced second quarter 2014 financial results.
Sign-up for Independence Realty Trust Announces Second Quarter 2014 Financial Results investment picks
2014/7/10
Independence Realty Trust, Inc. (NYSE MKT: IRT) (“IRT”) today announced that, on July 10, 2014, IRT’s Board of Directors declared monthly cash dividends for the third quarter of 2014 on IRT’s shares of common stock in the amount of $0.06 per share per month.
Sign-up for Independence Realty Trust Announces Third Quarter Monthly Cash Dividends on its Common Stock investment picks
2014/9/9
Independence Realty Trust, Inc. (“IRT”) (NYSE MKT: IRT) today announced the completion of the following two acquisitions of apartment communities for purchase prices aggregating $52.2 million: IRT funded the cash portion of these purchase prices with a portion of the net proceeds of IRT’s offering of its shares of common stock completed in July 2014.
Sign-up for Independence Realty Trust Completes Two Apartment Community Acquisitions Totaling $52.2 Million investment picks
2014/7/22
Independence Realty Trust, Inc. (NYSE MKT: IRT) (“IRT”) today announced that it expects to release its second quarter 2014 financial results before U.S. stock markets open on Friday, August 1, 2014 and invites investors and other interested parties to listen to its quarterly results conference call on Friday, August 1, 2014 at 9:00 a.m. Eastern time.
Sign-up for Independence Realty Trust Schedules Second Quarter 2014 Financial Results Release Date and Conference Call investment picks
2014/7/17
Independence Realty Trust, Inc. (NYSE MKT:IRT) (the “Company”), announced today the full exercise of the underwriters' option to purchase 1,050,000 additional shares of the Company's common stock.
Sign-up for Independence Realty Trust, Inc. Announces Full Exercise of Underwriters’ Option investment picks
2014/7/14
Independence Realty Trust, Inc. (NYSE MKT: IRT) (the "Company") today announced that it has commenced an underwritten public offering of 6,000,000 shares of common stock.
Sign-up for Independence Realty Trust, Inc. Announces Public Offering of Common Stock investment picks
2014/7/15
Independence Realty Trust, Inc. (NYSE MKT: IRT) (the "Company") today announced the pricing and upsizing of its public offering of 7,000,000 shares of common stock at a public offering price of $9.50 per share for total gross proceeds of approximately $66.5 million.
Sign-up for Independence Realty Trust, Inc. Prices and Upsizes Public Offering of Common Stock investment picks
COEUR D'ALENE, Idaho , June 19, 2014 /PRNewswire/ -- Independence Resources Plc (OTCBB: SNKTY) (the "Company") is pleased to provide an update on the status of the lawsuit that was filed against the Company by Miller Tabak + Co., LLC.
Sign-up for Independence Resources Prevails in Miller Tabak Legal Proceedings investment picks
The Board of Directors of Independent Bank Corp.
Sign-up for Independent Bank Corp. Announces Quarterly Dividend investment picks
Independent Bank Corp.
Sign-up for Independent Bank Corp. Reports Second Quarter Net Income of $14.7 Million investment picks
IONIA, Mich.
Sign-up for Independent Bank Corporation Reports 2014 Second Quarter Results investment picks
McKINNEY, Texas, July 29, 2014 (GLOBE NEWSWIRE) -- Independent Bank Group, Inc. (Nasdaq:IBTX) , the holding company for Independent Bank, today announced net income of $5.1 million, or $0.32 per diluted share, for the quarter ended June 30, 2014 compared to $4.8 million, or $0.38 per diluted share, for the quarter ended March 31, 2014 and pro forma after tax net income of $4.1 million, or $0.34 per diluted share, for the quarter ended June 30, 2013.
Sign-up for Independent Bank Group Reports Second Quarter Financial Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Incyte Announces Top-Line Results from RELIEF Trial of Ruxolitinib in Patients with Polycythemia Vera to Independent Bank Group Reports Second Quarter Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices